Merit Medical Systems Inc (MMSI)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Merit Medical Systems Inc (MMSI)
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.
Key Insights
Critical company metrics and information
Share Price
$104.40Market Cap
$6.08 BillionTotal Outstanding Shares
58.28 Million SharesTotal Employees
6,950Dividend
No dividendIPO Date
February 26, 1992SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.merit.com
Historical Stock Splits
If you bought 1 share of MMSI before August 15, 2003, you'd have 2.22 shares today.
Execution Date | Split Amount |
---|---|
May 6, 2011 | 5-for-4 |
December 3, 2003 | 4-for-3 |
August 15, 2003 | 4-for-3 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $462.13 Million |
Net Cash Flow From Operating Activities, Continuing | $214.31 Million |
Net Cash Flow | $462.13 Million |
Net Cash Flow From Financing Activities | $410.37 Million |
Net Cash Flow From Operating Activities | $214.31 Million |
Net Cash Flow From Investing Activities | $-162.55 Million |
Net Cash Flow From Investing Activities, Continuing | $-162.55 Million |
Net Cash Flow From Financing Activities, Continuing | $410.37 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Income/Loss | $120.04 Million |
Revenues | $1.33 Billion |
Operating Income/Loss | $152.74 Million |
Selling, General, and Administrative Expenses | $384.41 Million |
Diluted Earnings Per Share | $2.05 |
Net Income/Loss Available To Common Stockholders, Basic | $120.04 Million |
Diluted Average Shares | $118.20 Million |
Net Income/Loss Attributable To Parent | $120.04 Million |
Provision For Loan, Lease, And Other Losses | $1.27 Million |
Income Tax Expense/Benefit | $28.28 Million |
Operating Expenses | $468.14 Million |
Other Operating Expenses | $83.73 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Benefits Costs and Expenses | $1.18 Billion |
Gross Profit | $620.88 Million |
Costs And Expenses | $1.18 Billion |
Income/Loss From Continuing Operations After Tax | $120.04 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Nonoperating Income/Loss | $-4.43 Million |
Basic Earnings Per Share | $2.07 |
Cost Of Revenue | $704.99 Million |
Basic Average Shares | $116.35 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income/Loss From Continuing Operations Before Tax | $148.31 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Liabilities | $1.05 Billion |
Current Assets | $1.08 Billion |
Equity Attributable To Parent | $1.32 Billion |
Assets | $2.38 Billion |
Long-term Debt | $750.50 Million |
Liabilities And Equity | $2.38 Billion |
Inventory | $310.53 Million |
Equity | $1.32 Billion |
Fixed Assets | $389.65 Million |
Other Non-current Assets | $910.11 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Noncurrent Liabilities | $853.60 Million |
Current Liabilities | $201.08 Million |
Other Current Assets | $767.79 Million |
Other Non-current Liabilities | $103.09 Million |
Noncurrent Assets | $1.30 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Related Companies
View additional S&P 500 companies similar to Merit Medical Systems Inc (MMSI)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.